Stars on Trial: Clover's Appeal, the Copycat Suits and What's Next for 2027 Ratings

The 2027 Star Ratings are out, but the legal battles over how they're calculated are far from over. Two health law attorneys break down what the courts are being asked to decide, and what it could mean for your Star Ratings. 

From Clover's landmark court victory to a growing wave of lawsuits challenging CMS's Star Ratings methodology, the stakes for Medicare Advantage plans are enormous. With millions in quality bonus payments potentially on the line, the outcome of these cases could have far-reaching implications for the industry.

This isn't your typical Star Ratings webinar.

Join legal experts from Manatt, Phelps & Phillips, LLP and Georgetown University's O'Neill Institute for an inside look at the litigation challenging CMS's authority, the arguments being made in court, and what potential rulings could mean for Medicare Advantage organizations.

Go beyond the headlines to understand the legal challenges, financial implications, and uncertainty surrounding the 2027 ratings and beyond.

During this 60-minute complimentary webinar, you will:

• Get the legal perspective: Hear expert analysis of the arguments driving the Clover, SCAN, Alignment, Elevance, CareFirst, and Humana cases.
  
  
• Understand what’s at stake: Explore the key questions before the courts, including CMS’s authority to establish and modify Star Ratings measures.
  
  
• Connect the litigation to the 2027 ratings: Examine how pending cases and CMS’s June recalculation could affect health plans and future ratings.
  
  
• Assess the financial implications: Understand what’s driving multimillion-dollar bonus payment disputes and the potential consequences for Medicare Advantage organizations.
  
  
• Prepare for what comes next: Explore possible court outcomes and what quality, Stars, compliance, and finance teams should be watching.